Consider Pros and Cons of Tirzepatide for Obesity
August 2025
Tirzepatide (Zepbound) weekly injection will be a new option for obesity...now that it’s available in Canada to promote weight loss.
Tirzepatide is the same ingredient in Mounjaro for type 2 diabetes. It works similarly to semaglutide (Wegovy), but it’s a dual agonist...working at two receptor types instead of just one.
These meds increase satiety and slow gastric emptying...which may lead to weight loss in people with or without diabetes.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote